Skip to main content
SpringerLink
Log in

Background and Perspective

  • Chapter
  • First Online:
Autoimmune (IgG4-related) Pancreatitis and Cholangitis

  • 906 Accesses

Abstract

The recognition and characterization of autoimmune pancreatitis (AIP) and IgG4-related diseases (IgG4-RD) has evolved over the course of more than 50 years. The suggestion that chronic pancreatitis was sometimes caused by autoimmune mechanisms was mentioned in several publications beginning in 1959, but the recognition of characteristic clinical, imaging, and histopathologic features for such patients was not recorded until the 1990s. The characterization of AIP continues to be refined in multiple centers and countries. Heterogeneity in the histopathology among cases delayed the recognition of AIP, but ultimately led to the recognition of two subtypes, one of which occurs in the context of IgG4-RD. The recognition of IgG4-RD can be regarded as an outgrowth of the study of autoimmune pancreatitis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Nishimori I, Tamakoshi A, Otsuki M. Research Committee on Intractable Diseases of the Pancreas, Ministry of Health, Labour, and Welfare of Japan. Prevalence of autoimmune pancreatitis in Japan from a nationwide survey in 2002. J Gastroenterol. 2007;42(Suppl 18):6–8.

    Google Scholar 

  2. Pannala R, Chari ST. Autoimmune pancreatitis. Curr Opin Gastroenterol. 2008;24(5):591–6.

    Article  PubMed  CAS  Google Scholar 

  3. Sugumar A, Chari S. Autoimmune pancreatitis: an update. Expert Rev Gastroenterol Hepatol. 2009;3(2):197–204.

    Article  PubMed  Google Scholar 

  4. Kojima M, Sipos B, Klapper W, et al. Autoimmune pancreatitis: frequency, IgG4 expression, and clonality of T and B cells. Am J Surg Pathol. 2007;31(4):521–8.

    Article  PubMed  Google Scholar 

  5. Abraham SC, Wilentz RE, Yeo CJ, et al. Pancreaticoduodenectomy (Whipple resections) in patients without malignancy: are they all ‘chronic pancreatitis’? Am J Surg Pathol. 2003;27(1):110–20.

    Article  PubMed  Google Scholar 

  6. Hardacre JM, Iacobuzio-Donahue CA, Sohn TA, et al. Results of pancreaticoduodenectomy for lymphoplasmacytic sclerosing pancreatitis. Ann Surg. 2003;237(6):853–8.

    PubMed  Google Scholar 

  7. Weber SM, Cubukcu-Dimopulo O, Palesty JA, Suriawinata A, Klimstra D, Brennan MF, Conlon K. Lymphoplasmacytic sclerosing pancreatitis: inflammatory mimic of pancreatic carcinoma. J Gastrointest Surg. 2003;7(1):129–37.

    Article  PubMed  Google Scholar 

  8. Hughes DB, Grobmyer SR, Brennan MF. Preventing pancreaticoduodenectomy for lymphoplasmacytic sclerosing pancreatitis: cost effectiveness of IgG4. Pancreas. 2004;29(2):167.

    Article  PubMed  Google Scholar 

  9. Sah RP, Pannala R, Chari ST, et al. Prevalence, diagnosis, and profile of autoimmune pancreatitis presenting with features of acute or chronic pancreatitis. Clin Gastroenterol Hepatol. 2010;8(1):91–6.

    Article  PubMed  Google Scholar 

  10. Sarles H, Sarles JC, Muratore R, Guien C. Chronic inflammatory sclerosis of the pancreas—an autonomous pancreatic disease? Am J Dig Dis. 1961;6:688–98.

    Article  PubMed  CAS  Google Scholar 

  11. Suda K, Nishimori I, Takase M, Oi I, Ogawa M. Autoimmune pancreatitis can be classified into early and advanced stages. Pancreas. 2006;33(4):345–50.

    Article  PubMed  Google Scholar 

  12. Thal AP, Egner W, Murray MJ. Circulating antibodies in chronic pancreatitis. Surg Forum. 1959;10:240–3.

    Google Scholar 

  13. Murray MJ, Thal AP. The clinical significance of circulating pancreatic antibodies. Ann Intern Med. 1960;53:548–55.

    Article  PubMed  CAS  Google Scholar 

  14. Putzke HP. Morphology of acute and chronic pancreatitis. Z Gesamte Inn Med. 1979;34(10):266–71.

    PubMed  CAS  Google Scholar 

  15. Thal AP. The occurrence of pancreatic antibodies and the nature of the pancreatic antigen. Surg Forum. 1960;11:367–9.

    PubMed  CAS  Google Scholar 

  16. Freytag G, Kloppel G. Experimental pancreatitis and inflammation of the islets after treatment with immune sera against extract of pancreas of varying degrees of purity. Beitr Pathol Anat. 1969;139(2):138–60.

    PubMed  CAS  Google Scholar 

  17. Narula N, Vasudev M, Marshall JK. IgG4-related sclerosing disease: a novel mimic of inflammatory bowel disease. Dig Dis Sci. 2010;55(11):3047–51.

    Article  PubMed  CAS  Google Scholar 

  18. Gonatas NK, Howard JC. Inhibition of experimental allergic encephalomyelitis in rats severely depleted of T cells. Science. 1974;186(4166):839–41.

    Article  PubMed  CAS  Google Scholar 

  19. Ectors N, Maillet B, Aerts R, et al. Non-alcoholic duct destructive chronic pancreatitis. Gut. 1997;41(2):263–8.

    Article  PubMed  CAS  Google Scholar 

  20. Notohara K, Burgart LJ, Yadav D, Chari S, Smyrk TC. Idiopathic chronic pancreatitis with periductal lymphoplasmacytic infiltration: clinicopathologic features of 35 cases. Am J Surg Pathol. 2003;27(8):1119–27.

    Article  PubMed  Google Scholar 

  21. Davidson TS, Longnecker DS, Hickey WF. An experimental model of autoimmune pancreatitis in the rat. Am J Pathol. 2005;166(3):729–36.

    Article  PubMed  Google Scholar 

  22. Yoshida K, Toki F, Takeuchi T, Watanabe S, Shiratori K, Hayashi N. Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis. Dig Dis Sci. 1995;40(7):1561–8.

    Article  PubMed  CAS  Google Scholar 

  23. Kawaguchi K, Koike M, Tsuruta K, Okamoto A, Tabata I, Fujita N. Lymphoplasmacytic sclerosing pancreatitis with cholangitis: a variant of primary sclerosing cholangitis extensively involving pancreas. Hum Pathol. 1991;22(4):387–95.

    Article  PubMed  CAS  Google Scholar 

  24. Pearson RK, Longnecker DS, Chari ST, et al. Controversies in clinical pancreatology: autoimmune pancreatitis: does it exist? Pancreas. 2003;27(1):1–13.

    Article  PubMed  Google Scholar 

  25. Zamboni G, Luttges J, Capelli P, et al. Histopathological features of diagnostic and clinical relevance in autoimmune pancreatitis: a study on 53 resection specimens and 9 biopsy specimens. Virchows Arch. 2004;445(6):552–63.

    Article  PubMed  Google Scholar 

  26. Kloppel G, Detlefsen S, Chari ST, Longnecker DS, Zamboni G. Autoimmune pancreatitis: the clinicopathological characteristics of the subtype with granulocytic epithelial lesions. J Gastroenterol. 2010;45(8):787–93.

    Article  PubMed  Google Scholar 

  27. Chari ST, Kloeppel G, Zhang L, Notohara K, Lerch MM, Shimosegawa T. Autoimmune Pancreatitis International Cooperative Study Group (APICS). Histopathologic and clinical subtypes of autoimmune pancreatitis: the Honolulu consensus document. Pancreas. 2010;39(5):549–54.

    Google Scholar 

  28. Shimosegawa T, Kanno A. Autoimmune pancreatitis in Japan: overview and perspective. J Gastroenterol. 2009;44(6):503–17.

    Article  PubMed  CAS  Google Scholar 

  29. Kamisawa T, Funata N, Hayashi Y, et al. A new clinicopathological entity of IgG4-related autoimmune disease. J Gastroenterol. 2003;38(10):982–4.

    Article  PubMed  CAS  Google Scholar 

  30. Kamisawa T, Okamoto A. Autoimmune pancreatitis: proposal of IgG4-related sclerosing disease. J Gastroenterol. 2006;41(7):613–25.

    Article  PubMed  CAS  Google Scholar 

  31. Hamano H, Kawa S, Horiuchi A, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med. 2001;344(10):732–8.

    Article  PubMed  CAS  Google Scholar 

  32. Kamisawa T, Okamoto A. IgG4-related sclerosing disease. World J Gastroenterol. 2008;14(25):3948–55.

    Article  PubMed  CAS  Google Scholar 

  33. Ghazale A, Chari ST, Smyrk TC, et al. Value of serum IgG4 in the diagnosis of autoimmune pancreatitis and in distinguishing it from pancreatic cancer. Am J Gastroenterol. 2007;102(8):1646–53.

    Article  PubMed  CAS  Google Scholar 

  34. Frulloni L, Scattolini C, Falconi M, et al. Autoimmune pancreatitis: differences between the focal and diffuse forms in 87 patients. Am J Gastroenterol. 2009;104(9):2288–94.

    Article  PubMed  Google Scholar 

  35. Tan Sardjono C, Mottram PL, Hogarth PM. The role of FcgammaRIIa as an inflammatory mediator in rheumatoid arthritis and systemic lupus erythematosus. Immunol Cell Biol. 2003;81(5):374–81.

    Article  PubMed  Google Scholar 

  36. Detlefsen S, Bräsen J, Zamboni G, Capelli P, Klöppel G. Deposition of complement C3c, immunoglobulin (Ig)G4 and IgG at the basement membrane of pancreatic ducts and acini in autoimmune pancreatitis. Histopathology. 2010;57:825–35.

    Article  PubMed  Google Scholar 

  37. Pradhan V, Patwardhan GK. Fc gamma receptor polymorphisms in systemic lupus erythematosus and their correlation with the clinical severity of the disease. Indian J Hum Genet. 2008;14(3):77–81.

    Article  PubMed  CAS  Google Scholar 

  38. van Schie RC, Wilson ME. Evaluation of human FcgammaRIIA (CD32) and FcgammaRIIIB (CD16) polymorphisms in Caucasians and African-Americans using salivary DNA. Clin Diagn Lab Immunol. 2000;7(4):676–81.

    PubMed  Google Scholar 

Download references

Acknowledgment

The author thanks William F. Hickey, Günter Klöppel, and Thomas Smyrk for suggestions during the preparation of this chapter.

Author information

Authors and Affiliations

  1. Department of Pathology, Geisel School of Medicine at Dartmouth, Dartmouth-Hitchcock Medical Center, One Medical Center Drive, Lebanon, NH, 03756, USA

    Daniel S. Longnecker M.D.

Authors
  1. Daniel S. Longnecker M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Daniel S. Longnecker M.D. .

Editor information

Editors and Affiliations

  1. and Hepatology, Mayo Clinic Division of Gastroenterology, Rochester, Minnesota, USA

    Michael J. Levy

  2. and Hepatology, Mayo Clinic Division of Gastroenterology, Rochester, Minnesota, USA

    Suresh T. Chari

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media New York

About this chapter

Cite this chapter

Longnecker, D.S. (2013). Background and Perspective. In: Levy, M., Chari, S. (eds) Autoimmune (IgG4-related) Pancreatitis and Cholangitis. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-6430-4_1

Download citation

  • DOI: https://doi.org/10.1007/978-1-4419-6430-4_1

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4419-6429-8

  • Online ISBN: 978-1-4419-6430-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation